Monday, March 21, 2022 2:50:49 PM
8k
Item 1.02 Termination of a Material Definitive Agreement
Termination of MidCap Credit Agreement
As previously disclosed, on September 25, 2020, Exicure, Inc. (“Exicure”) and Exicure Operating Company, Exicure’s wholly owned subsidiary (collectively with Exicure, the “Company”), entered into a Credit and Security Agreement (as amended, restated, amended and restated, supplemented or otherwise modified from time to time, the “MidCap Credit Agreement”) with MidCap Financial Trust, as agent, and the lenders party thereto from time to time.
On March 15, 2022, the Company repaid in full all outstanding indebtedness and other obligations under the MidCap Credit Agreement and other Financing Documents (as defined in the MidCap Credit Agreement) and terminated all obligations thereunder (other than with respect to any obligations that are expressly specified to survive the termination).
Item 1.02 Termination of a Material Definitive Agreement
Termination of MidCap Credit Agreement
As previously disclosed, on September 25, 2020, Exicure, Inc. (“Exicure”) and Exicure Operating Company, Exicure’s wholly owned subsidiary (collectively with Exicure, the “Company”), entered into a Credit and Security Agreement (as amended, restated, amended and restated, supplemented or otherwise modified from time to time, the “MidCap Credit Agreement”) with MidCap Financial Trust, as agent, and the lenders party thereto from time to time.
On March 15, 2022, the Company repaid in full all outstanding indebtedness and other obligations under the MidCap Credit Agreement and other Financing Documents (as defined in the MidCap Credit Agreement) and terminated all obligations thereunder (other than with respect to any obligations that are expressly specified to survive the termination).
Recent XCUR News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/10/2026 08:15:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2026 08:15:02 PM
- Summary Notice of Pendency and Proposed Settlement of Stockholder Derivative Actions • GlobeNewswire Inc. • 04/02/2026 08:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/27/2026 08:40:30 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/25/2026 08:42:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/25/2026 08:32:21 PM
- Exicure, Inc. Reports Full Year 2025 Financial Results • GlobeNewswire Inc. • 03/25/2026 08:18:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/17/2026 10:25:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/10/2026 09:25:41 PM
- Exicure Announces Publication in Annals of Hematology Highlighting Rapid Stem Cell Mobilization with Burixafor in Patients with Multiple Myeloma and Lymphoma Undergoing Transplant • GlobeNewswire Inc. • 02/05/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2026 09:29:08 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 01/21/2026 06:21:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/21/2026 05:46:19 PM
- Exicure to Present Data from Burixafor Phase 2 Trial at the 2026 Tandem Meetings • GlobeNewswire Inc. • 01/21/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/20/2026 07:09:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2026 01:42:41 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/11/2025 01:51:19 AM
- Exicure Presents Positive Topline Phase 2 Data for Burixafor in Multiple Myeloma at 2025 ASH Annual Meeting • GlobeNewswire Inc. • 12/08/2025 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/19/2025 04:50:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/17/2025 09:52:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/10/2025 09:17:16 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/07/2025 09:18:23 PM
